Glenmark Pharmaceuticals Ltd.
2,474.50+22.6 (+0.92%)
8 Sep, 3:30 PM
Annual Reports and Financial Documents
Glenmark Pharmaceuticals Ltd. annual reports, quarterly results, earnings call transcripts and investor presentations. All official filings in one place.
Corporate Announcements and Regulatory Filings
Glenmark Pharmaceuticals Ltd. BSE/NSE disclosures, board meeting outcomes, insider trading notifications, acquisitions and other regulatory filings.
- Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseGlenmark Pharmaceuticals Inc., USA launches Calcium Gluconate Injection USP, 1,000 mg/10 mL (100 mg/mL), 5,000 mg/50 mL (100 mg/mL) Single-Dose Vials and 10,000 mg/100 mL (100 mg/mL) Pharmacy ....
- Regulation 30(5) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 - List Of OfficialsPlease find attached Company''s officials authorised for the purpose of determining materiality of an event or information and making disclosures to the Stock Exchanges
- Board Meeting Outcome for Board Meeting Outcome - Unaudited Standalone And Consolidated Financial Results For The Quarter Ended June 30, 2026The Board of Directors has considered and approved the Unaudited Standalone and Consolidated Financial Results for the quarter ended June 30, 2026
Frequently Asked Questions
Where can I download the annual report of Glenmark Pharmaceuticals Ltd.?
Annual reports of Glenmark Pharmaceuticals Ltd. are available for download in the Annual Reports and Financial Documents section of the Resources tab, organised by financial year.
Where can I find the quarterly results of Glenmark Pharmaceuticals Ltd.?
Quarterly earnings results and presentations of Glenmark Pharmaceuticals Ltd. are available in the Annual Reports and Financial Documents section of the Resources tab. Detailed financials are also in the Statements tab.
Does Glenmark Pharmaceuticals Ltd. publish earnings call transcripts?
Earnings call transcripts of Glenmark Pharmaceuticals Ltd., where available, are listed in the Annual Reports and Financial Documents section of the Resources tab.
Where can I find investor presentations of Glenmark Pharmaceuticals Ltd.?
Investor presentations and annual day presentations of Glenmark Pharmaceuticals Ltd. are listed in the Resources tab under Annual Reports and Financial Documents.
What are the recent corporate announcements of Glenmark Pharmaceuticals Ltd.?
Corporate announcements and regulatory filings of Glenmark Pharmaceuticals Ltd. as submitted to BSE and NSE are available in the Corporate Announcements and Regulatory Filings section of the Resources tab.
How do I access the regulatory filings of Glenmark Pharmaceuticals Ltd.?
Regulatory filings including board meeting outcomes, insider trading disclosures and other exchange notifications of Glenmark Pharmaceuticals Ltd. are in the Corporate Announcements and Regulatory Filings section of the Resources tab.
What is the ISIN of Glenmark Pharmaceuticals Ltd.?
The ISIN (International Securities Identification Number) of Glenmark Pharmaceuticals Ltd. is INE935A01035. This is the unique identifier used across exchanges and depositories.
On which stock exchange is Glenmark Pharmaceuticals Ltd. listed?
Glenmark Pharmaceuticals Ltd. is listed on NSE and BSE. The NSE symbol is GLENMARK and the BSE code is -.
Where can I find the shareholding pattern of Glenmark Pharmaceuticals Ltd.?
The quarterly shareholding pattern of Glenmark Pharmaceuticals Ltd. showing promoter, FII, DII, mutual fund and public holdings is available in the Shareholding Pattern section on the Overview tab.
How current is the data for Glenmark Pharmaceuticals Ltd. on Sharpely?
Share price data for Glenmark Pharmaceuticals Ltd. is updated as of 8 Sep 2026. Financial statements, shareholding and other fundamental data are updated after each quarterly disclosure.